{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T02:37:43Z","timestamp":1648521463689},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ijcard.2014.04.163","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T07:31:18Z","timestamp":1398151878000},"page":"836-838","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Enterococcus faecalis bacteremia and mitral valve endocarditis under dabigatran for stroke prevention"],"prefix":"10.1016","volume":"174","author":[{"given":"Claudia","family":"St\u00f6llberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Finsterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.04.163_bb0005","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.04.163_bb0010","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1160\/TH13-03-0246","article-title":"Contra: \u201cnew oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation\u201d","volume":"110","author":"St\u00f6llberger","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijcard.2014.04.163_bb0015","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/dmd.107.019083","article-title":"The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans","volume":"36","author":"Blech","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ijcard.2014.04.163_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","article-title":"Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study","volume":"49","author":"Stangier","year":"2010","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2014.04.163_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-939550","article-title":"An overview of the structure and function of thrombin","volume":"32","author":"Davie","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ijcard.2014.04.163_bb0030","doi-asserted-by":"crossref","first-page":"e51313","DOI":"10.1371\/journal.pone.0051313","article-title":"Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsis","volume":"7","author":"Kalle","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2014.04.163_bb0035","doi-asserted-by":"crossref","first-page":"e1002307","DOI":"10.1371\/journal.ppat.1002307","article-title":"Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood","volume":"7","author":"McAdow","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijcard.2014.04.163_bb0040","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1076029607305580","article-title":"Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis","volume":"13","author":"Ravindranath","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ijcard.2014.04.163_bb0045","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1021\/jm3001339","article-title":"Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2)","volume":"55","author":"Michaelis","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijcard.2014.04.163_bb0050","doi-asserted-by":"crossref","first-page":"30917","DOI":"10.1074\/jbc.M605809200","article-title":"NQO1 and NQO2 regulation of humoral immunity and autoimmunity","volume":"281","author":"Iskander","year":"2006","journal-title":"J Biol Chem"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314008432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314008432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T19:20:38Z","timestamp":1538680838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314008432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0167527314008432"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.163","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enterococcus faecalis bacteremia and mitral valve endocarditis under dabigatran for stroke prevention","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}